We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Micromolded Gelatin Scaffolds for Extended In Vitro Culture of Muscle Tissue

By LabMedica International staff writers
Posted on 13 Jul 2016
A novel in vitro method for growing muscle tissue for an extended period of time depends on minute scaffolds constructed from gelatin.

Gelatin is an irreversibly hydrolyzed form of collagen, wherein the hydrolysis results in the reduction of protein fibrils into smaller peptides, which have broad molecular weight ranges.

Culturing skeletal muscle in vitro has been problematic due to myotube delamination from synthetic culture substrates approximately one week after initiating differentiation from myoblasts. More...
However, in the current study, investigators at the University of Southern California (Los Angeles) successfully maintained aligned skeletal myotubes differentiated from C2C12 mouse skeletal myoblasts for three weeks.

To accomplish this advance in culture technology, the investigators utilized micromolded gelatin hydrogels as culture substrates. The hydrogels were thoroughly characterized using atomic force microscopy (AFM).

The investigators reported in the June 28, 2016, online edition of the journal Scientific Reports that compared to polydimethylsiloxane (PDMS) microcontructs printed with fibronectin (FN), cell adhesion on gelatin hydrogel constructs was significantly higher one week and three weeks after initiating differentiation. Delamination from FN-microprinted PDMS prevented detection of myotubes.

Compared to a softer blend of PDMS microprinted with FN, myogenic index, myotube width, and myotube length on micromolded gelatin hydrogels was similar one week after initiating differentiation. However, three weeks after initiating differentiation, these parameters were significantly higher on micromolded gelatin hydrogels compared to FN-microprinted soft PDMS constructs.

"Disease and disorders involving skeletal muscle - ranging from severe muscular dystrophies to the gradual decrease in muscle mass with aging - dramatically reduce the quality of life for millions of people," said senior author Dr. Megan L. McCain, assistant professor of biomedical engineering at the University of Southern California. "By creating an inexpensive and accessible platform for studying skeletal muscle in the laboratory, we hope to enable research that will usher in new treatments for these patients."

Related Links:
University of Southern California



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Immunofluorescence Analyzer
IFA System
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.